Metfaith PG 1mg/500mg/15mg Tablet SR
Marketer
Indiabulls pharmaceutical ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metfaith PG 1mg/500mg/15mg Tablet SR
Glucobalance Trio 1mg/500mg/15mg Extended-Release Tablets combine ingredients to manage blood glucose. This medication complements diet and exercise for improved glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, thus reducing blood sugar. Follow your physician's prescribed dosage and regimen for Glucobalance Trio. Take with food to prevent digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; skip the missed dose then. Never double a dose. Excessive intake can cause hypoglycemia (low blood sugar). Concomitant use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Consult your doctor before use if you have kidney, liver, or heart disease, or if pregnant or breastfeeding. Kidney function tests will be performed prior to treatment. Limit alcohol consumption as it may heighten adverse effects.
Uses of Metfaith PG 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metfaith PG 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Metfaith PG 1mg/500mg/15mg Extended-Release Tablet with food.
Common Side effects of Metfaith PG 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metfaith PG 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metfaith PG 1mg/500mg/15mg Extended-Release tablet should be administered with a meal.
How Metfaith PG 1mg/500mg/15mg Tablet SR works:
Metfaith PG SR tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications act via separate pathways to optimize blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Finally, pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Metfaith PG 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Metfaith PG 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Metfaith PG 1mg/500mg/15mg tablet's use while breastfeeding is likely inadvisable. Insufficient human evidence indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Metfaith PG 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Metfaith PG 1mg/500mg/15mg SR tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Metfaith PG 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Metfaith PG 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Metfaith PG 1mg/500mg/15mg Tablet SR :
Should you forget to take your Metfaith PG 1mg/500mg/15mg Tablet SR, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metfaith PG 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently